Form 4 for AGL agilon health, inc.
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-15 | 2021-09-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.50 | +11.5K | 16.9K | +211% | +$51.6K |
| D | 2021-09-15 | 2021-09-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $28.98 | -11.5K | 5,434 | -68% | -$332.5K |
| D | 2021-09-15 | 2021-09-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $0.00 | -11.5K | 538.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | M | A | 11,475 | $4.50 | 16,909 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2021-09-14 | S | D | 11,475 | $28.98 | 5,434 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2021-09-14 | M | D | 11,475 | $0.00 | 538,525 | D | $4.50 · — to 2030-01-31 | 11,475 Common Stock | (F2) These options were granted on January 31, 2020. 25% of the options vested on January 9, 2021 and the remaining options are scheduled to vest in three equal installments on each anniversary of January 9, 2021, subject to continued employment. |